Novel triazolopyridylbenzamides as potent and selective p38 alpha inhibitors.
Aiguade, J., Balague, C., Carranco, I., Caturla, F., Dominguez, M., Eastwood, P., Esteve, C., Gonzalez, J., Lumeras, W., Orellana, A., Preciado, S., Roca, R., Vidal, L., Vidal, B.(2012) Bioorg Med Chem Lett 22: 3431-3436
- PubMed: 22521646 
- DOI: 10.1016/j.bmcl.2012.03.099
- Primary Citation of Related Structures:  
3S3I - PubMed Abstract: 
A new class of p38α inhibitors based on a biaryl-triazolopyridine scaffold was investigated. X-ray crystallographic data of the initial lead compound cocrystallised with p38α was crucial in order to uncover a unique binding mode of the inhibitor to the hinge region via a pair of water molecules ...